
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: Results from a randomised, controlled, double-blind trial
Keywords: Alum; aluminium hydroxide; AS04; aluminium hydroxide and 3-O-deacylated monophosphoryl lipid A adjuvant system; ATP; according to protocol; 95% CI; 95% confidence interval; ELISA; enzyme-linked immunosorbent assay; EU; ELISA units; gD2; herpes simplex vir